Trading
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We’d like to highlight our low float of just over 23 million as well as a low total outstanding of a little over 65 million.
New HOD $CBDW
Big $$ rolling in!
New HOD incoming! $CBDW
Lunch is over! $CBDW to .05 !!
C..
B..
D..
W..
Next leg up! $CBDW
All eyes on $CBDW !!
L2 is thin to .05 $CBDW
$CBDW Signs Letter of Intent to Acquire a Strategic Stake in Adnexus, a Leading AI Biotech Company https://finance.yahoo.com/news/1606-corp-signs-letter-intent-120000809.html
1606 Corp. Signs Letter of Intent to Acquire a Strategic Stake in Adnexus, a Leading AI Biotech Company
SEATTLE, WA / ACCESSWIRE / September 4, 2024 / 1606 Corp. (OTC Pink:CBDW), a leader in AI technology development, is pleased to announce that it has signed a nonbinding Letter of Intent (LOI) to acquire a strategic stake in Adnexus, a pioneering company at the forefront of Artificial Intelligence innovations in early drug discovery and infectious disease research.
This potential strategic investment underscores 1606 Corp.'s commitment to expanding its technological footprint and enhancing its capabilities in the rapidly evolving field of AI. We believe the integration of Adnexus's cutting-edge AI research and development expertise would significantly bolster 1606 Corp.'s portfolio, bringing advanced solutions to the intersection of artificial intelligence and healthcare and biotech.
Adnexus has been recognized for its groundbreaking work in leveraging AI to drive early drug discovery and develop critical treatments for infectious diseases including HIV and SARS-COV-2. By aligning with Adnexus, 1606 Corp. aims to accelerate innovation and development within the healthcare sector, combining its strengths in conversational AI and chatbot technology with Adnexus's pioneering research efforts. For a deeper dive into Adnexus' groundbreaking technology, visit their website at www.adnexusbiotech.com.
Adnexus has distinguished itself in the field of biotechnology through its innovative approach to developing therapeutic solutions. Their proprietary methodology is centered around utilizing human "immune-B cells" sourced from individuals who have naturally recovered from target viruses. This unique process enables the creation of fully human monoclonal antibodies that exhibit natural affinity and specificity.
Austen Lambrecht, CEO of 1606 Corp., stated, "We are thrilled to enter into this agreement with Adnexus. Their exceptional work in AI-driven drug discovery and infectious disease treatment aligns perfectly with our vision of harnessing advanced AI technologies to create impactful solutions. This partnership represents a significant step forward in our strategy to diversify and enhance our technological capabilities."
The transaction is expected to be finalized following customary due diligence and the fulfillment of certain conditions as stated in the LOI. Both companies anticipate that this strategic alignment will generate significant value for shareholders, advance technological development, and drive innovation in their respective fields.
CEO, Austen Lambrecht and 1606 Corp. (CBDW) are glad to announce that we will be presenting at the 150th NIBA Show in Fort Lauderdale on Thursday, August 5th.
Good Morning $XONI
Good Morning $CBDW
$XONI HUGE NEWS
DETROIT, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Xtreme One Entertainment, Inc. (OTCPink: XONI) (the “Company” or “Xtreme One”) today announced that its Board of Directors approved a comprehensive strategic plan to continue investing in the Company’s sports brands and accelerating events under the Xtreme Fighting Championships (XFC) MMA property. The Company also announced the finalization of its Regulation 1-A registration statement (Reg A+ Offering) to raise up to $10 million in equity to fund its accelerating events, operations, and to pursue strategic acquisitions.
Xtreme One also announced the engagement of Chicago-based L J Soldinger Associates, LLC to complete a two-year audit to accompany the Company’s planned filing of a Form 10 registration statement and to qualify for listing on the OTCQB exchange. The move to a fully reporting OTCQB company is anticipated to occur in the fourth quarter of 2024.
“This strategic growth plan reflects the shared vision of our Board to build a premier media and entertainment company centered on MMA and other extreme sports and making the XFC the leading development league in the MMA space,” said Jeff Lambert, Board Chair of Xtreme One. “Growing our organization and growing our profile as a public company go hand in hand, and we have a front-row seat to the insatiable demand by fans and investors alike for live sports events and properties. The uplisting to OTCQB and ultimately NASDAQ has been part of our transformation plan since the beginning, and we know raising the Company’s profile will attract the right investors, improve our liquidity, and open the door for more sports fans, fighters and savvy investors to invest in our success.”
The Company intends to use the capital raised from the Reg A+ Offering for continued investment in the production of live events, which it believes will build the Company’s sports brands and drive long-term shareholder value. Management believes that raising the profile of its brand and events will enhance Xtreme One’s ability to attract key talent and sponsors to drive long-term sustainable growth in revenue and enhance profitability. The use of proceeds also includes pursuing strategic acquisitions, licensing agreements and content, and new media and entertainment properties to compliment its global XFC property and operation.
“This capital infusion will allow us to accelerate our pace of live events, including relaunching our ‘Young Guns’ series focused on developing the next generation of MMA fighters, and reintroducing international XFC events starting in Latin America, the birthplace of MMA and the XFC,” added Chris Defendis, president of Xtreme One. “As we grow and attract rising, top-tier talent from across the globe, we intend to raise the bar for what extreme events can be. The Board and management team are locked in on the game plan for sustainable growth and maximizing shareholder value.”
Good Morning $KAYS
Good Morning $CBDW
Good Morning $CBDW
$KAYS New Psilocybin center featured on KATU News! (VIDEO)
https://katu.com/news/local/willamette-week-psilocybin-center-piloting-new-business-plan
Good Morning $CBDW
Good Morning $CBDW
Low float monster $KAYS
Good Morning $KAYS
Good Morning $CBDW
$CBDW Strategic Plans: Q3 2024: Spotlight: NIBA Show in Florida
https://cbdw.ai/1606-corps-strategic-plans-for-q3-2024-spotlight-on-the-niba-show-in-florida/
$KAYS New Psilocybin center featured on KATU News! (VIDEO)
https://katu.com/news/local/willamette-week-psilocybin-center-piloting-new-business-plan
Good Morning $CBDW
Nice start here $KAYS #Shrooms
51 for you
Good Morning $CBDW
Time to crack .03's ! $CBDW
Good Morning $KAYS
Good Morning $CBDW
.0247 up
Red to Green imo .. #trading101 $CBDW